The Tuberculin Skin Test (TST) involves the injection of tuberculin or PPD (purified protein derivative), a mixture of purified proteins from the M. Tuberculosis bacterium, under the skin. The test is designed to measure delayed-type hypersensitivity reactions. In infected individuals, the body will recognize the antigens in the Tuberculin serum and cause a local reaction at the site of injection. The degree of reaction (size of the induration created) is read 42 to 78 hours after injection. False positive results may occur with recent BCG vaccination (within the past five years). The test will not detect infection in individuals with recently infected or in those with compromised immune systems, such as HIV positive, those on certain immunosuppressive drugs (e.g. beta blockers used in treatment for xxxxx), or . The most widely used form of the test is the Mantoux Skin Test, which consists of an intradermal injection on the underside of the forearm. The earlier forms of the TST, the Time Test, involving multiple small punctures on the underside of the forearm, may still be used in some areas. |

Induration created by the Mantoux Skin Test. The size of a positive test result depends on the exposure history and health status of the individual and a measure of the actual induration rather than the erythema produced:
Patient Status |
Positive Result |
HIV + |
>5mm |
Healthy individuals with exposure history or risk factors |
>10mm |
Healthy individuals with no exposure history |
>15mm |
|